In these three short-term cases, the CardioWrap® Bioresorbable Protective Sheet has proven to be a cost effective and an inert product for pericardium replacement in procedures which may require reoperation within six months. However, these three cases are short-term observations and should be interpreted accordingly. Further investigation is absolutely required to determine the efficacy of the CardioWrap® sheet in other cardiac surgery procedures in which re-entry is likely (e.g. congenital cases, young adults).

Download Article